2) Lily will now seek expanded emergency use authorization from the FDA. The detailed numbers are linked below.https://twitter.com/DrEricDing/status/1352241211508142082 …
-
-
Show this thread
-
3) Unlike vaccines that trains / teaches your bodies how to recognize the spike protein and build your own immunity, monoclonal antibody drugs directly infuse working synthetic antibodies against the virus into your system. This is useful for people with slower immune systems.
Show this thread -
4) MAB drugs (also made by Regeneron) also useful in early
#COVID19, which it is currently used for, as long as illness isn’t severe yet. but unclear how it would mix with vaccines. Govt rules currently says avoid mixing for 3 months initially. But maybe updated soon.Show this thread -
5) And yes, MAB drugs are designed for the classic older variant. Unclear on efficacy against new variants. But it can be updated over time with extra work and testing.
Show this thread -
6) That said, some have speculated extended use of MAB drugs could be also driving mutations as well—since it forces evolution of viruses via extra selective pressure. Some say the same for overuse of convalescent plasma therapy. But similar argument on antibiotic overuse too.
Show this thread -
7) But do we stop using antibiotics for bacteria infections? No, but there is some risk of antibiotic resistance long term. But it buys us time. MAB drugs are not a way out of this pandemic. Vaccines are. But maybe a temporary stopgap.
Show this thread -
8) Also note that unlike vaccines, MAB drugs wanes quickly within weeks. Vaccine derived immunity should be robust for much longer - especially with the 2nd dose. MAB drugs also slows your body from building its own immune defense to the virus too.
Show this thread -
9) This is akin to “giving a person a fish to feed for a day”, as opposed to “teaching a person how to fish” like vaccines do. Teaching how to fish is much better long term. So MAB drugs are a stopgap temporary measure.
Show this thread -
10) MAB drugs are also pain in the rear to mass produce. They can’t be chemically synthesized like molecules in typical drugs can. They must be made by slow biological reactors that create them slowly. So much slower on mass production.
Show this thread -
11) Also worrisome, neutralization by 14 of the 17 most potent mAbs tested in one study was reduced or abolished by either K417N, or E484K, or N501Y mutations (found in the most recent South Africa
#B1351 and Brazil
#P1 variants). Not good.https://www.biorxiv.org/content/10.1101/2021.01.15.426911v1 …Show this thread
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.